Evidence map›Paper›PMID 27956793›Full record

ReviewWorld journal of gastroenterology2016

Epidemiology of pancreatic cancer.

Milena Ilic, Irena Ilic

4 registry-linked trialsAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 699 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
699citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04582461 unknown statusnot on this mapstarted 2021, after this paper: background citation

Role of Preoperative Multislice Computed Tomography to Predict the Risk of Pancreatic Fistula After Whipple's Operation.

TypeobservationalSponsorAssiut UniversityRan2021 to 2022Enrolled100ConditionsPancreatic FistulaArmsmultislice computed tomography
NCT04986215 unknown statusnot on this mapstarted 2020, after this paper: background citation

Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy

TypeobservationalSponsorChanghai HospitalRan2020 to 2023Enrolled300ConditionsPancreatic Space Occupying
NCT06050317 phase2recruitingnot on this mapstarted 2023, after this paper: background citation

Sintilimab Plus Chemotherapy and Radiotherapy for Patients With Inoperable Pancreatic Cancer: a Single-arm, Exploratory, Phase II Trial

TypeinterventionalSponsorShandong Cancer Hospital and InstituteRan2023 to 2026Enrolled25ConditionsPancreas CancerArmsSintilimab Plus mFFN or NALIRIFOX and Radiation
NCT06615830 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

HIPANC-002 - Observational Performance Study of Transcriptome-Based OncoTreat/OncoTarget Testing With Patient-Derived Organoids in Metastatic Pancreatic Cancer

TypeobservationalSponsorProf. Dr. med. Dres. h.c. Jan Schmidt, MMERan2026 to 2031Enrolled185ConditionsPancreas Neoplasms, Pancreatic Neoplasms, Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic
3 · Its place in the literature

Who cites it

699 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

639 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Milena IlicMilena Ilic, Irena Ilic, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Irena IlicMilena Ilic, Irena Ilic, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer of the pancreas remains one of the deadliest cancer types. Based on the GLOBOCAN 2012 estimates, pancreatic cancer causes more than 331000 deaths per year, ranking as the seventh leading cause of cancer death in both sexes together. Globally, about 338000 people had pancreatic cancer in 2012, making it the 11

Indexed as

AgedAged, 80 and overAge DistributionFemaleHumansIncidenceMaleMiddle AgedPancreatic NeoplasmsPrognosisRisk AssessmentRisk FactorsTime FactorsEpidemiologyIncidenceMortalityPancreatic cancerRisk factorsTrend

Identifiers

PMID27956793
PMCPMC5124974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.